Skip to content

GoldiloxBio

Plug and Play · Transforming Drug Discovery with models that reflect human physiology.

Competitors

Adjacent

Also from Plug and Play in AI

All of Plug and Play

Programs

Programs GoldiloxBio went through
ProgramCohortSource
Plug and PlayNot statedPlug and Play Page

About GoldiloxBio

GoldiloxBio is an innovative lifetech company focused on transforming drug discovery through the development of advanced assays that accurately predict human toxicities. By integrating hardware, software, and biomaterials, the company recreates critical aspects of human physiology in vitro to provide drug developers with predictive, human-relevant data. This approach addresses the limitations of traditional animal models, offering faster, more cost-effective, and reliable insights that help de-risk drug candidates before clinical trials. GoldiloxBio’s platform aims to accelerate development timelines and improve clinical success rates by delivering actionable information on drug safety. The company’s initial service focuses on cardiotoxicity testing, with ongoing efforts to enhance data interpretation through machine learning. GoldiloxBio’s contributions represent a significant advancement in preclinical testing, supporting innovation in drug development and reducing reliance on less predictive models.

Category
AI, Developer tools
Location
United States
Checked
2h ago

GoldiloxBio: questions

Which accelerators did GoldiloxBio go through?

GoldiloxBio is listed by Plug and Play.

Where is GoldiloxBio based?

GoldiloxBio lists United States as its location on Plug and Play's page.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.